Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to investigate whether P-wave duration in a baseline surface 12-lead ECGs correlates with recurrence of AF recurrence post successful ablation at the time of the procedure.


Clinical Trial Description

Patients with paroxysmal AF are often treated arrhythmia-free (75%) with a single catheter ablation at 12 months post procedure . In contrast, in patients with persistent AF or long persistent AF, catheter ablation is more complex and often yields in lower success rates of around 50% often requiring multiple attempts . The success rates remain low despite several different ablation sites having been proposed (additional lines plus PVI, epicardial approach). There is growing evidence that PWD is associated with the extent of left atrial scarring and this can be used a potential predictor of AF recurrence . Moreover, results from the investigators group has previously shown that PWD correlated with the duration of the AF and this could be altered by extensive ablation . It is uncertain whether PWD prior to any procedure for persistent AF, long persistent or paroxysmal AF can accurately predict failure of procedure. This is a single centre observational study of persistent, long persistent and paroxysmal AF population who have undergo AF cryoablation in University Hospital Plymouth . All patients receive this current procedure as standard of care. This study does not involve any patient contact out of the standard routine clinical follow up and therefore no public involvement has been sought. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04968678
Study type Observational [Patient Registry]
Source University Hospital Plymouth NHS Trust
Contact Guy Haywood, MBBD,MD
Phone 07785955893
Email guyhaywood@nhs.net
Status Recruiting
Phase
Start date May 13, 2021
Completion date May 13, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT05266144 - Atrial Fibrillation Patients Treated With Catheter Ablation
Recruiting NCT06202209 - The Impact of Autonomic Function on Atrial Fibrillation Recurrence After Pulmonary Vein Ablation
Not yet recruiting NCT04780438 - Dapagliflozin to Prevent Atrial Fibrillation Recurrence After Transcatheter Pulmonary Venous Isolation. Early Phase 1
Not yet recruiting NCT06098989 - A Prospective Study of REPeat Ablation In Patients With Recurrent PERSistent Atrial Fibrillation: Pulmonary Vein Isolation vs. Adjunct Posterior Wall Isolation (REPAIR PERS-AF Study) N/A
Recruiting NCT05781282 - Pulmonary Vein (PV) Imaging by Intracardiac Echography (ICE) After Ablation Phase 4
Terminated NCT04704050 - Effect of Dronedarone on Atrial Fibrosis Progression and Atrial Fibrillation Recurrence Phase 4
Completed NCT04964440 - Redo AF Sub Study (of the Pure EP 2.0 Main Study)
Not yet recruiting NCT06204640 - SPironolactONe for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation Phase 3
Recruiting NCT06253000 - Radiofrequency and Cryoablation of the Posterior Wall of the Left Atrium N/A
Not yet recruiting NCT06199180 - Pulsed Field Ablation Versus Conventional Radiofrequency Catheter Ablation for Repeat PVI in Patients With Paroxysmal AF N/A
Recruiting NCT03075930 - Atrial Fibrillation Ablation Registry
Recruiting NCT05528419 - Sacubitril Valsartan in Preventing the Recurrence of Atrial Fibrillation After Ablation in Elderly Hypertensive Patients With Atrial Fibrillation Phase 4
Not yet recruiting NCT06130358 - Investigating the Effects of a Museum Intervention on the Psychological and Cardiac Health of Older Adults N/A
Completed NCT05486364 - DIGITal mOnitoring afTer Af abLation N/A
Recruiting NCT05159180 - Development of a New Impedance Mapping System for Ablation of Atrial Arrhythmias in Patients
Active, not recruiting NCT06111443 - Effect of Dapagliflozin on the Recurrence of Atrial Tachyarrhythmia in Patients Undergoing Catheter Ablation of Atrial Fibrillation Phase 2/Phase 3